Calisha Myers

Calisha Myers

Stories by Calisha Myers

What can we expect from Obama's FDA?

The principal question facing President Obama's FDA will not revolve around drug safety or transparency, says Robert Goldberg, Co-founder and vice president of the Center for Medicines in the Public

Post-Gazette responds to Mylan lawsuit

Over the past month, the Pittsburgh Post-Gazette newspaper has offered little comment on Mylan's (MYL) decision to sue the paper over articles that led to an FDA investigation of the drugmaker's

Lupin snags Antara rights for $38.6M

Back in January, Oscient Pharmaceuticals filed a patent infringement lawsuit against India's Lupin Pharmaceuticals (LUPN) over the cholesterol drug Antara (fenofibrate). Just days ago, Lupin

Novo Nordisk to add 400 to Indian staff

Novo Nordisk (NVO) will likely increase its workforce in India by 400 over the next three to five years, the drugmaker said in an interview with Danish daily Jyllands-Posten today. The developer,

Juvaris completes $25M close of series B

Adjuvant vaccines developer Juvaris BioTherapeutics has completed the first close of a Series B round. The Burlingame, CA-based company says it will use the capital to advance its technology platform

AIDS activists grade pharma

The AIDS Activists Coalition released its Pharmaceutical Company HIV/AIDS Report Card last week and they're not all exactly the kind of report cards you want to take home to mom. Nine companies were